These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 8045961

  • 1. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A, Simberg N, Stenman UH, Ylikorkala O.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [Abstract] [Full Text] [Related]

  • 2. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E, Janni A, Lobo RA.
    J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
    [Abstract] [Full Text] [Related]

  • 3. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
    Simberg N, Tiitinen A, Silfvast A, Viinikka L, Ylikorkala O.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):646-51. PubMed ID: 8636283
    [Abstract] [Full Text] [Related]

  • 4. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1716-22. PubMed ID: 7989480
    [Abstract] [Full Text] [Related]

  • 5. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL, Monroe SE, Jaffe RB.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [Abstract] [Full Text] [Related]

  • 7. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 8. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
    Azziz R, Ochoa TM, Bradley EL, Potter HD, Boots LR.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A, Fusco A, Magnani A, Marini MA, Di Daniele N, Gatti S, Lauro R.
    Exp Clin Endocrinol Diabetes; 1995 Apr; 103(1):15-20. PubMed ID: 7621099
    [Abstract] [Full Text] [Related]

  • 11. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Apr; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 12. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U.
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [Abstract] [Full Text] [Related]

  • 14. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Bayhan G, Bahçeci M, Demirkol T, Ertem M, Yalinkaya A, Erden AC.
    Clin Exp Obstet Gynecol; 2000 Feb; 27(3-4):203-6. PubMed ID: 11214952
    [Abstract] [Full Text] [Related]

  • 17. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR, Poznanski N.
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [Abstract] [Full Text] [Related]

  • 18. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K, Erkkola R, Kaihola HL, Santti R, Irjala K.
    Acta Obstet Gynecol Scand; 1985 Apr; 64(8):629-33. PubMed ID: 2938400
    [Abstract] [Full Text] [Related]

  • 19. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R.
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [Abstract] [Full Text] [Related]

  • 20. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
    Rittmaster RS.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.